Multiple-viruses IVDs
ARTG ID: 414738 · Australia Health Products Central Pty Ltd · Hangzhou Fanttest Biotech Co Ltd · Class IIb · Started July 27, 2023
Good Name: Australia Health Products Central Pty Ltd - Multiple-viruses IVDs
- Risk Class
- Class IIb
- Product Type
- IVD
- ARTG Category
- IVD
- ARTG ID
- 414738
- Start Date
- July 27, 2023
- Effective Date
- September 11, 2024
- Country
- China
- Address
- Room 201 Building 1 No 37-3 Futang Road Tangqi Town Linping District, Hangzhou City, Zhejiang Province
Intended to detect influenza A/B and the novel coronavirus SARS-CoV-2 by lateral flow immunoassay from symptomatic individuals for self-testing by lay person (nasal swab).
Access comprehensive regulatory information for Multiple-viruses IVDs in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is registered under ARTG number 414738 and sponsored by Australia Health Products Central Pty Ltd, manufactured by Hangzhou Fanttest Biotech Co Ltd in China. The device registration started on July 27, 2023.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.